Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus
Clinical trial NCT02761629 · COMPLETED
Trial details
- NCT number
- NCT02761629
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2008-05-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.